Mini Review - Journal of Advanced Surgical Research (2025) Volume 9, Issue 3
Organ transplantation: Innovations, ethics, global challenges
Ahmed El-Sayed*
Department of Transplant Surgery, Cairo University Medical Center, Cairo, Egypt
- *Corresponding Author:
- Ahmed El-Sayed
Department of Transplant Surgery
Cairo University Medical Center, Cairo, Egypt.
E-mail: ahmed.elsayed@cairotransplant.eg
Received : 04-Jul-2025, Manuscript No. aaasr-216; Editor assigned : 08-Jul-2025, PreQC No. aaasr-216(PQ); Reviewed : 28-Jul-2025, QC No aaasr-216; Revised : 06-Aug-2025, Manuscript No. aaasr-216(R); Published : 15-Aug-2025 , DOI : 10.35841/2591-7765-9.3.216
Citation: El-Sayed A. Organ transplantation: Innovations, ethics, global challenges. aaasr. 2025;09(03):216.
Introduction
This article updates clinicians on the crucial aspects of managing kidney transplant recipients around the time of surgery. It specifically addresses modern immunosuppression protocols, strategies for preventing and treating infections common in this population, and the management of cardiovascular complications, which remain a leading cause of morbidity and mortality. Ensuring optimal patient outcomes requires a meticulous approach to these complex factors, emphasizing both immediate post-operative care and long-term health stabilization methods. The focus here is on integrated care to enhance graft survival and patient well-being, acknowledging the multi-faceted challenges faced by both patients and clinicians in this specialized field.[1].
This overview tackles the complex global challenges impacting organ transplantation. It highlights disparities in access, ethical considerations, and the need for international collaboration to address organ shortages, improve outcomes, and prevent organ trafficking, emphasizing the human rights aspect of organ donation. Addressing these global disparities is paramount for achieving equitable access to life-saving transplants worldwide. Effective policy-making and cross-border cooperation are essential to overcome these significant hurdles and foster a more just system for organ allocation and donation.[2].
This review delves into the latest innovations in liver transplantation, covering advancements in surgical techniques, immunosuppression, organ preservation methods, and donor selection. It also explores emerging frontiers like machine perfusion and cell-based therapies, offering insights into future directions for improving patient survival and quality of life. These innovations are continually reshaping the possibilities within liver transplantation, promising more effective treatments and broader applicability for patients in need. The integration of technology and biological research is a key driver in this progress, leading to less invasive procedures and better post-operative recovery.[3].
This article reviews significant advancements in pancreas transplantation, a vital treatment for patients with type 1 diabetes and end-stage renal disease. It discusses improved patient selection, surgical techniques, immunosuppressive regimens, and management of complications, highlighting the evolving role of this complex procedure in metabolic control. The procedure offers a pathway to potentially achieve insulin independence and significantly improve the quality of life for suitable candidates. Ongoing research aims to further refine techniques and minimize risks, making this a more viable option for a wider patient demographic.[4].
This paper examines current practices and outcomes in adult heart transplantation. It covers patient selection criteria, donor management, surgical techniques, and post-transplant care, including long-term immunosuppression and complication management. It also provides insights into contemporary survival rates and quality of life improvements. The success of heart transplantation relies on a meticulous, multidisciplinary approach, from the initial assessment to lifelong follow-up, ensuring the best possible outcome for patients with end-stage heart disease. This comprehensive care model addresses both physical and psychological aspects of recovery and adaptation.[5].
This comprehensive review traces the evolution of lung transplantation from its early challenges to its current state. It discusses improvements in surgical techniques, immunosuppressive regimens, and organ preservation, while also exploring future directions, including ex vivo lung perfusion and gene therapy, to enhance long-term outcomes and expand donor pools. The journey reflects a remarkable triumph over initial difficulties, now offering hope to many. Further innovations are poised to increase the availability of viable organs and improve the durability of transplant success, making a profound impact on patients' lives.[6].
This article highlights the dawning of a new era for islet transplantation as a therapeutic option for individuals with severe type 1 diabetes. It outlines the progress in refining techniques for islet isolation, improving immunosuppression to prevent rejection, and enhancing long-term graft function, aiming to achieve insulin independence and stable glycemic control. The promise of islet transplantation lies in its potential to offer a less invasive solution for managing diabetes, reducing reliance on external insulin administration and mitigating disease complications. Continuous advancements in the field are crucial for realizing its full therapeutic potential.[7].
This concise review provides an essential overview of immunosuppression strategies in solid organ transplantation. It discusses the mechanisms of action, clinical applications, and side effect profiles of key immunosuppressive drugs, highlighting the balance between preventing rejection and minimizing adverse events like infection and malignancy. Striking the right balance is critical for long-term graft survival and patient health, requiring personalized treatment plans and vigilant monitoring. The evolution of immunosuppressive therapies continues to be a cornerstone of transplant medicine, constantly seeking more effective and safer regimens.[8].
This article explores the significant benefits and inherent risks associated with living donor kidney transplantation. It emphasizes the superior long-term outcomes for recipients, but also delves into the critical considerations for donor safety, ethical dilemmas, and the comprehensive evaluation process required to protect both parties. The decision to pursue living donation involves careful weighing of advantages against potential risks for the donor, making the thorough evaluation process indispensable. This ethical framework ensures the well-being and informed consent of all involved, upholding the highest standards of medical practice.[9].
This review discusses the transformative role of machine perfusion in optimizing organ preservation for transplantation. It highlights how this technology improves organ assessment, mitigates ischemia-reperfusion injury, and potentially expands the donor pool by allowing for the safe utilization of organs that might otherwise be deemed unsuitable, leading to better post-transplant outcomes. Machine perfusion represents a significant leap forward in organ viability, offering a pathway to reduce discard rates and enhance the overall success of transplantation procedures. Its continued development promises to further revolutionize organ procurement and preparation.[10].
Conclusion
The landscape of organ transplantation is continually evolving, marked by significant advancements in surgical techniques, immunosuppression, and organ preservation across various organs. Key updates highlight the crucial aspects of managing kidney transplant recipients around surgery, addressing modern immunosuppression protocols, infection prevention, and cardiovascular complication management. The field also confronts complex global challenges, including disparities in access to organs, ethical considerations, the persistent issue of organ shortages, and the critical need to combat organ trafficking, emphasizing the human rights dimension of donation. Innovations in liver transplantation are pushing boundaries with new surgical methods, advanced immunosuppression strategies, and improved organ preservation techniques like machine perfusion, alongside exploring cell-based therapies to enhance patient survival. Similar progress is seen in pancreas transplantation, vital for type 1 diabetes and end-stage renal disease patients, where refined patient selection, surgical approaches, and immunosuppressive regimens are improving metabolic control. Adult heart transplantation practices have evolved, focusing on meticulous patient and donor management, surgical precision, and comprehensive post-transplant care, leading to better long-term survival and quality of life. Lung transplantation has journeyed from early difficulties to its current advanced state, benefiting from improved techniques and the exploration of future directions such as ex vivo lung perfusion and gene therapy to broaden donor pools and enhance outcomes. Islet transplantation is entering a new era for type 1 diabetes, with advancements in islet isolation, immunosuppression to prevent rejection, and efforts to improve long-term graft function for insulin independence. Underpinning these advances is a focus on immunosuppression strategies for solid organ transplants, carefully balancing the prevention of rejection with minimizing adverse effects like infection and malignancy. The benefits and inherent risks of living donor kidney transplantation are also carefully examined, emphasizing superior recipient outcomes balanced against critical donor safety considerations and ethical dilemmas. Finally, machine perfusion technology is transforming organ preservation, allowing for better organ assessment, reduced ischemia-reperfusion injury, and the potential expansion of the donor pool by safely utilizing previously unsuitable organs.
References
- Anjali S, Rita BM, Bertram LK. Perioperative Management of Kidney Transplant Recipients: An Update on Immunosuppression, Infections, and Cardiovascular Complications. Clin J Am Soc Nephrol. 2023;18(10):1335-1347.
- Francis LD, James FM, Jace H. Global Challenges in Organ Transplantation: An Overview. Semin Liver Dis. 2021;41(2):105-115.
- Jean CE, Elizabeth CV, Milan K. Innovations in Liver Transplantation: Current Practices and Future Perspectives. Gastroenterology. 2022;162(5):1361-1376.
- David AA, Ronald SS, Timothy LP. Advances in Pancreas Transplantation: A Review. Clin Transplant. 2020;34(12):e14138.
- Kiran KK, William SC, Adnan K. Heart Transplantation in Adults: Current Practices and Outcomes. J Am Coll Cardiol. 2019;73(19):2419-2433.
- Ankit B, Samuel K, Peter P. Lung Transplantation: The Past, Present, and Future. J Thorac Dis. 2023;15(5):2465-2476.
- Michelle DB, Frederick BB, Bernhard JH. Islet Transplantation for Type 1 Diabetes: A New Era. Diabetes Care. 2020;43(5):940-949.
- Joan MG, Josep MC, Oriol B. Immunosuppression in Solid Organ Transplantation: A Concise Review. Nephron. 2021;145(2):149-161.
- Rahul G, Aneesh P, Jeremy C. Living Donor Kidney Transplantation: Benefits and Risks. Semin Nephrol. 2022;42(4):304-314.
- Ina J, Jacques P, Dirk VR. The Role of Machine Perfusion in Organ Preservation for Transplantation. Transplantation. 2023;107(1):4-15.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref